Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anite Philip
Observed name:
A. Philip
Institutions:
National Center for Cancer Care and Research,
Hamad Medical Corporation
Observed institutions:
National Center for Cancer Care and Research,
Hamad Medical Corporation
ORCID:
0000-0003-0875-0466
Observed ORCID:
0000-0003-0875-0466
OpenAlex ID:
A5010221919
Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients
2023
·
Shayista Akbar
, Afsheen Raza
, et al.
·
Frontiers in Immunology
·
70
Quality of Life, Sleep Quality, Depression, Anxiety, Stress, Eating Habits, and Social Bounds in Nurses during the Coronavirus Disease 2019 Pandemic in Qatar (The PROTECTOR Study): A Cross-Sectional, Comparative Study
2021
·
Abdulqadir J. Nashwan
, Ralph C. Villar
, et al.
·
Journal of Personalized Medicine
·
56
PDF
Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression
2023
·
Afsheen Raza
, Reyad Mohsen
, et al.
·
Frontiers in Immunology
·
15
17 Predictive soluble biomarkers of immune response to checkpoint blockade in non-small cell lung cancer (NSCLC) patients
2021
·
Afsheen Raza
, Reyad Mohsen
, et al.
·
Journal for ImmunoTherapy of Cancer
·
4
PDF
Uro‐genital oncology synergy: Accelerating treatment with multidisciplinary joint counseling clinic
2025
·
Eftikar M. Al‐Yafei
, Emelita Ison
, et al.
·
UroPrecision
·
1
PDF
627 Soluble immune modulatory cytokines and immune checkpoint molecules as predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients
2025
·
Kirti S Prabhu
, Sarra Mestiri
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Understanding and Overcoming Barriers to Admissions and Timely Discharges in a Cancer Hospital: A Case Study of National Centre for Cancer Care and Research, Doha, Qatar
2024
·
Abdul Rehman Zar Gul
, Anite Philip
, et al.
·
The Open Public Health Journal
15P Serum immune checkpoint biomarkers as predictors of response to anti-PD-1/PD-L1 treatment in non-small cell lung cancer (NSCLC) patients
2021
·
A. Raza
, R. Mohsin
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
8
Citation count:
146
H-index:
4
I10-index:
3
Year
Topic
Type